Renee Bullock-Palmer is a Cardiology physician affiliated with Investigators Research Group. OpenAlex indexes 85 publications with 4,819 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Trenton Rd
Deborah Heart And Lung Hospital
Browns Mills, NJ 080151705
Telephone
609-893-6611Registry record last updated 12 Apr 2012.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20251 payment
- Janssen Pharmaceuticals, IncProgram year20241 payment
- Novo Nordisk IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.7%Statin25.1%Atorvastatin Calcium55%Rosuvastatin Calcium32%Lovastatin6%Simvastatin5%Pravastatin Sodium3%Part D<11 patientsBeta blocker14.9%Carvedilol41%Metoprolol Succinate39%Metoprolol Tartrate14%Atenolol6%Part D<11 patients+ 13 more classes in this area
Blood & clotting
9.3%Factor Xa inhibitor3.5%Eliquis79%Xarelto21%Part D<11 patientsP2Y12 inhibitor3.3%Clopidogrel100%Part D≥31 patients+ 1 more class in this area
Metabolism & gastrointestinal
7%Potassium supplement6.5%Potassium Chloride100%Part D≥55 patientsSGLT2 inhibitor0.5%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging
Journal of the American College of Cardiology
2025 - Adult Congenital Heart Disease as a Career? Examining Encouraging and Deterring Factors in the Global ACHD Survey
Journal of the American Heart Association
2025 - 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR advanced training statement on advanced cardiovascular imaging
Journal of Nuclear Cardiology
2025 - Global opportunities in nuclear cardiology: Perspectives on growth in the Middle East, Latin America, and Europe
Journal of Nuclear Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Prabhjot Nijjar, MD
Investigators Research Group
Sorin Danciu, MD
Investigators Research Group
Talal Alnabelsi, MD
Investigators Research Group
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”